Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT06550323

Effect of Virtual Reality Application on Pain, Anxiety and Comfort During Chest Tube Removal Procedure

Chest tubes are used to eliminate possible acute or chronic problems that may occur after trauma or surgical interventions to the chest area. This process, which aims to drain the fluid, blood or air accumulated in the pleural area, works with the support of closed underwater drainage systems. The chest tubes, which remain in place for a long time, fuse with the endothelium lying in the chest cavity. For this reason, the adhesions formed with the fusion cause very severe acute pain in the patient with the pulling force applied during removal.The high level of pain of the person will cause an increase in the level of anxiety and a decrease in the level of comfort. The anxiety experienced by the patients will also reduce the tolerance to pain.It has been observed that the use of virtual reality in the field of health significantly reduces the level of pain and anxiety during medical procedures, shortens wound healing and hospital stay, and increases compliance with treatment.In the literature, no studies were found in which the effects of virtual reality application on pain, anxiety and comfort were evaluated in patients whose chest tube was removed.Thereforee, this study was conducted to evaluate the effect of virtual reality application against all these negative situations.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ataturk University

Erzurum, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

  • Study Inclusion Criteria:
  • Must be between the ages of 18-65,
  • Must have undergone coronary artery bypass graft surgery and have a chest tube,
  • Must participate in the study voluntarily,
  • Must not have vision or hearing problems,
  • Must not have disorientation in place and time,
  • Must not have any psychiatric disorders,
  • Study Exclusion Criteria:
  • Those with chronic pain and routinely using painkillers,
  • Those using painkillers before the procedure,
  • Those with problems such as migraine, vertigo, dizziness,
  • Patients using prescription glasses and those having vision problems without glasses were not included in the study.

Treatment and study plan

Group using virtual reality glasses

Device

Group using virtual reality glasses: During the procedure, individuals will wear glasses.

Primary outcomes

  1. visual analog scale

    Time frame: 5 month

    To evaluate pain severity, pain results are evaluated by scoring between 0-10. While 0 indicates "No pain", 10 indicates "Unbearable pain".

    The minimum value is 0 and the maximum value is 10. 0 represents a good result and 10 represents a bad result

  2. State-Trait Anxiety Inventory Scale

    Time frame: 5 month

    It is a 4-point Likert-type scale with 40 items and is scored as "never": 1, "a little": 2, "a lot": 3, "completely": 4, according to the degree of severity of the feelings, thoughts or behaviors expressed by the items. anxiety level will be determined.

  3. comfort scale

    Time frame: 5 month

    It is a scale ranging from 0 to 10 points. While 0 points indicate 'most comfortable', 10 points indicate 'most uncomfortable'.

    The minimum value is 0 and the maximum value is 10. 0 represents a good result and 10 represents a bad result

  4. verbal pain scale

    Time frame: 5 month

    0 points indicate "No pain", 1 point indicates "Mild pain", 2 points indicate "Moderate pain" and 3 points indicate "Severe pain".

Sponsors and collaborators

Lead sponsor

Hale Rumeysa Seçer

Other

Registry information

Official study title

Göğüs Tüpü Çıkarma İşlemi Sırasında Sanal Gerçeklik Uygulamasının Ağrı, Anksiyete ve Konfora Etkisi

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 13, 2024
Registry last updated
Aug 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.